CRSP
CRISPR Therapeutics AG · Healthcare
CEO Samarth Kulkarni sold $1.0M of CRISPR Therapeutics AG
Sold$1,023,290
$40.93Price
25,000Shares
−6%Stake
What CRSP did after the filing
- The stock from Fri, Dec 30 close, $40.65
- +25.1%
- S&P 500, same days
- +7.9%
Measured over 30 trading days, to the Feb 14 close.
Traded Wed, Dec 28. Filed Fri, Dec 30, 12:33 PM ET, during the session. Returns use the Dec 30 close and the Feb 14 close. Not investment advice.